Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group.

Autor: Witchitz S (AUTHOR), Cohen-Solal A (AUTHOR), Dartois N (AUTHOR), Weisslinger N (AUTHOR), Juste K (AUTHOR), Darmon JY (AUTHOR), CELICARD Group (CORPORATE AUTHOR), Witchitz, S1 (AUTHOR), Cohen-Solal, A (AUTHOR), Dartois, N (AUTHOR), Weisslinger, N (AUTHOR), Juste, K (AUTHOR), Darmon, J Y (AUTHOR)
Zdroj: American Journal of Cardiology. 06/15/2000, Vol. 85 Issue 12, p1467-1471. 5p.
Databáze: Academic Search Ultimate
Externí odkaz: